Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05661474Phase 4Completed
Phase 4, randomised, open-label trial of triticum vulgare aqueous extract in diabetic foot ulcer (DFU) (2 arms), sponsored by University of Naples Federico II. Primary endpoint: Proportion of patients complete responders at 12 weeks. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05661474.